Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Vital Farms Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while Vital Farms Inc trades at $9 (market cap $382.95M). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 13.3× Vital Farms Inc's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Vital Farms Inc for 15 Days on average.
| ORKA | VITL | |
|---|---|---|
Market Cap | $5.08B | $382.95M |
Volume | 685,276 | 1,912,535 |
Sector | Health | Consumer Staples |
52-Week High | $113.08 | $40.85 |
52-Week Low | $26.19 | $8.28 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $4.21B | $469.96M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Vital Farms (VITL) trades at $9.34, down 1.37% with bearish technical signals and mixed fundamentals. The company reported Q2 2026 revenue of $166 million (down 10.1% YoY) but beat expectations, while net income margins collapsed to near-zero levels. Recent news includes potential strategic options exploration and institutional buying activity despite challenging industry conditions.
The stock faces headwinds from egg pricing pressure and oversupply issues, though analyst consensus remains positive with a $13.11 price target. Key risks include margin compression and industry volatility, while potential upside exists from strategic alternatives and pasture-raised egg demand recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
